Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus

NCT05056935 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Ileus

Interventions

DRUG: LB1148
DRUG: Placebo

Sponsor

Newsoara Biopharma Co., Ltd.